Cargando…

Preparation and Characterization of Fe(3)O(4)@MTX Magnetic Nanoparticles for Thermochemotherapy of Primary Central Nervous System Lymphoma in vitro and in vivo

BACKGROUND: Primary central nervous system lymphomas (PCNSL) are extranodal malignant non-Hodgkin lymphomas (NHL) that arise exclusively in central nervous system (CNS). Diffuse large B-cell lymphoma (DLBCL) is the most common histological subtype. PURPOSE: To evaluate whether nano drug-loading syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xinyu, Yao, Jingqing, Zhong, Yuejiao, Li, Yuntao, Lu, Qianling, Zhang, Yan, Tian, Xue, Guo, Zhirui, Bai, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901047/ https://www.ncbi.nlm.nih.gov/pubmed/31824157 http://dx.doi.org/10.2147/IJN.S205456

Ejemplares similares

Preparation and characterization of Fe(3)O(4)@Au-C225 composite targeted nanoparticles for MRI of human glioma
por: Ge, Yaoqi, et al.
Publicado: (2018)

Thermochemotherapy-induced resistance to cyclophosphamide.
por: Urano, M., et al.
Publicado: (1988)

Sensitizing thermochemotherapy with a PARP1-inhibitor
por: Oei, Arlene L, et al.
Publicado: (2016)

Fe(3)O(4)@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells
por: Lu, Qianling, et al.
Publicado: (2018)

Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy
por: Kleef, R., et al.
Publicado: (2012)

PB2347: THE ROLE OF UPFRONT LENALIDOMIDE MAINTENANCE FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS RESPONDING TO FIRST-LINE MTX TREATMENT
por: Zhang, Yan, et al.
Publicado: (2023)

Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese
por: Han, Xiao, et al.
Publicado: (2017)

Multifunctional Nanographene Oxide for Targeted Gene-Mediated Thermochemotherapy of Drug-resistant Tumour
por: Zeng, Yiping, et al.
Publicado: (2017)

Hyaluronic Acid Modified Hollow Prussian Blue Nanoparticles Loading 10-hydroxycamptothecin for Targeting Thermochemotherapy of Cancer
por: Jing, Lijia, et al.
Publicado: (2016)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
por: Verkaaik, M, et al.
Publicado: (2011)

Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
por: Affleck, K., et al.
Publicado: (1992)

Impairment of Methotrexate (MTX)‐Polyglutamate Formation of MTX‐resistant K562 Cell Lines
por: Koizumi, Shoichi
Publicado: (1988)

ML-13 AN ATTEMPT OF RECHALLENGE OF HD-MTX AND MAINTENANCE THERAPY OF MTX FOR PATIENTS WITH PCNSL
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

Use of S2.2/DOX Magnetic Nanoliposomes in MR Molecule Imaging and Targeted Thermochemotherapy for Breast Cancer In Vitro
por: Zhu, Yinxing, et al.
Publicado: (2023)

Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
por: Zhang, Le, et al.
Publicado: (2020)

A case report of primary central nervous system lymphoma with intestinal obstruction as the initial symptom
por: Li, Xiaoke, et al.
Publicado: (2018)

Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo
por: Li, Yuntao, et al.
Publicado: (2011)

Implementation of an Outpatient HD-MTX Initiative
por: Sokol, Kelsey, et al.
Publicado: (2022)

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2
por: De La Fuente, A., et al.
Publicado: (2022)

Efficacy of salvage therapy with MTX-HOPE for elderly patients with heavily pretreated non-Hodgkin’s lymphoma
por: Fukunaga, Akiko, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Rare central nervous system lymphomas
por: Kaji, Furqaan Ahmed, et al.
Publicado: (2022)

Thermochemotherapy effect of nanosized As(2)O(3)/Fe(3)O(4 )complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9
por: Du, Yiqun, et al.
Publicado: (2009)

How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy
por: Taylor, Peter. C., et al.
Publicado: (2019)

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
por: Emery, Paul, et al.
Publicado: (2020)

Construction of Multifunctional Fe(3)O(4)-MTX@HBc Nanoparticles for MR Imaging and Photothermal Therapy/Chemotherapy
por: Zhang, Qiang, et al.
Publicado: (2018)

Research on the Damage of the Central Nervous System Lymphoma to the Nervous System
por: Hernandez, Jairo, et al.
Publicado: (2023)

GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells
por: Wang, Ling, et al.
Publicado: (2015)

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
por: Vieira-Sousa, Elsa, et al.
Publicado: (2020)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Central Nervous System Lymphoma Masquerading as Neurosarcoidosis
por: Arakawa, Akira, et al.
Publicado: (2020)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis
por: Fleischmann, Roy, et al.
Publicado: (2016)

Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia
por: Sari, Nur Melani, et al.
Publicado: (2021)

MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma
por: Suzuki, Manabu, et al.
Publicado: (2021)

Complete Genome Sequence of Serratia marcescens Phage MTx
por: Graham, Kristin, et al.
Publicado: (2019)

Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?
por: Matsuo, Toshihiko, et al.
Publicado: (2019)

Primary central nervous system lymphomas express immunohistochemical factors of autophagy
por: Karpathiou, Georgia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kn38v6kgn6bth39sfpa1s9oudt